🇺🇸 FDA
Pipeline program

Cam2020 M2SR H3N2 influenza vaccine

FLUGEN-H3N2-V006

Phase 1 mab completed

Quick answer

Cam2020 M2SR H3N2 influenza vaccine for Influenza Vaccine is a Phase 1 program (mab) at UNITED THERAPEUTICS Corp with 1 ClinicalTrials.gov record(s).

Program details

Company
UNITED THERAPEUTICS Corp
Indication
Influenza Vaccine
Phase
Phase 1
Modality
mab
Status
completed

Clinical trials